Raising Growth Capital Through the IPO and Public Offering
First written in FY2020. 17 of 18 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2026.
30 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「1 August 2025–31 January 2026 43,500 4,608,400 7 596 7 546／Increase due to the exercise of stock acquisition rights.」
During the consolidated fiscal year, the company issued 64,200 shares through the exercise of stock acquisition rights, increasing capital and the capital surplus by ¥10 million each. - FY2026-H1AdvancedAnnual report
「1 August 2025–31 January 2026 (Note 1) 43,500 4,608,400 7 596 7 546 / (Note 1) This increase resulted from the exercise of stock acquisition rights. 2. Between 1 February 2026 and 28 February 2026, the exercise of stock acquisition rights increased the total number of issued shares by 13,800 and increased share capital and capital reserves by ¥2 million each.」
During the current interim consolidated accounting period, the Company issued 43,500 shares through the exercise of stock acquisition rights, followed by a further 13,800 shares in February 2026, after the period ended. Equity financing has continued after listing. - FY2025AdvancedAnnual report
「1 August 2024–31 July 2025 (Note 3) 44,100 4,564,900 7 589 7 539 / (Note 3) This increase resulted from the exercise of stock acquisition rights.」
During the current consolidated fiscal year, the Company issued 44,100 shares through the exercise of stock acquisition rights, increasing share capital and capital reserves by ¥7 million each. Equity financing has continued after listing. - FY2025-H1AdvancedAnnual report
「1 August 2024–31 January 2025 (Note 1) 8,100 4,528,900 1 583 1 533 / Note 2. Between 1 February 2025 and 28 February 2025, the exercise of stock acquisition rights increased the total number of issued shares by 30,300 and increased share capital and capital reserves by ¥4 million each.」
During the current interim consolidated accounting period, the Company issued 8,100 shares through the exercise of stock acquisition rights, followed by a further 30,300 shares in February 2025, after the period ended. Capital raising through the exercise of stock acquisition rights has continued after listing. - FY2024AdvancedAnnual report
「Net cash used in financing activities was ¥1,305 million (compared with ¥817 million provided in the previous consolidated fiscal year). This was mainly attributable to ¥2,039 million used for the repayment of long-term borrowings, partly offset by ¥1,131 million in proceeds from long-term borrowings. / Proceeds from the issuance of bonds 297」
In addition to conventional borrowings and share issuance, the Company issued ¥300 million of bonds in March 2024, securing funding through multiple financing methods. - FY2024-Q3AdvancedAnnual report
「1 February 2024–30 April 2024 (Note 1) 4,500 4,519,300 0 581 0 531 / (Note 1) This increase resulted from the exercise of stock acquisition rights. 2. Between 1 May 2024 and 31 May 2024, the exercise of stock acquisition rights increased the total number of issued shares by 1,500 and increased share capital and capital reserves by ¥0 million each.」
During the third quarter, 4,500 shares were issued through the exercise of stock acquisition rights, followed by a further 1,500 shares in May, after the end of the quarter. Capital raising through the exercise of stock acquisition rights has continued after listing. - FY2024-Q2AdvancedAnnual report
「1 November 2023–31 January 2024 (Note 1) 900 4,514,800 0 580 0 530 / (Note 1) This increase resulted from the exercise of stock acquisition rights. 2. Between 1 February 2024 and 29 February 2024, the exercise of stock acquisition rights increased the total number of issued shares by 4,500 and increased share capital and capital reserves by ¥0 million each.」
During the second quarter, 900 shares were issued through the exercise of stock acquisition rights, followed by a further 4,500 shares in February 2024, after the end of the quarter. Capital raising through the exercise of stock acquisition rights has continued after listing. - FY2024-Q1AdvancedAnnual report
「Between 1 November 2023 and 30 November 2023, the exercise of stock acquisition rights increased the total number of issued shares by 900 and increased share capital and capital reserves by ¥0 million each.」
Following the exercise of stock acquisition rights after the end of the quarter, 900 shares were issued, and capital raising through the exercise of stock acquisition rights continued after listing. - FY2023AdvancedAnnual report
「1 August 2022–31 July 2023 (Note 4) 36,600 4,513,900 6 580 6 530」
During the current consolidated fiscal year, the Company issued 36,600 shares through the exercise of stock acquisition rights, increasing share capital and capital reserves by ¥6 million each. - FY2023-Q2AdvancedAnnual report
「Between 1 February 2023 and 28 February 2023, the exercise of stock acquisition rights increased the total number of issued shares by 1,200 and increased share capital and capital reserves by ¥0 million each.」
Through the exercise of stock acquisition rights, 1,200 shares were issued in February 2023, after the end of the quarter, and capital raising through the exercise of stock acquisition rights continued after listing. - FY2022AdvancedAnnual report
「1 August 2021–31 July 2022 (Note 5) 156,300 4,477,300 25 574 25 524 / (Note 5) This increase resulted from the exercise of stock acquisition rights.」
During the fiscal year ended July 2022, the Company issued 156,300 shares through the exercise of stock acquisition rights, increasing share capital and capital reserves by ¥25 million each. - FY2022-Q3AdvancedAnnual report
「1 February 2022–30 April 2022 (Note 1) 38,700 4,465,600 6 572 6 522 / (Note 1) This increase resulted from the exercise of stock acquisition rights. 2. Between 1 May 2022 and 31 May 2022, the exercise of stock acquisition rights increased the total number of issued shares by 11,700 and increased share capital and capital reserves by ¥1 million each.」
The Company issued 38,700 shares through the exercise of stock acquisition rights during the third quarter and a further 11,700 shares the following May. - FY2022-Q2AdvancedAnnual report
「Between 1 February 2022 and 28 February 2022, the exercise of stock acquisition rights increased the total number of issued shares by 38,700 and increased share capital and capital reserves by ¥6 million each.」
Through the exercise of stock acquisition rights, 38,700 shares were issued in February 2022, after the end of the quarter, increasing share capital and capital reserves by ¥6 million each. - FY2022-Q1AdvancedAnnual report
「Change in the total number of issued shares: 61,800 shares. This increase resulted from the exercise of stock acquisition rights. 2. Between 1 November 2021 and 30 November 2021, the exercise of stock acquisition rights increased the total number of issued shares by 44,100 and increased share capital and capital reserves by ¥7 million each.」
The Company issued 61,800 shares through the exercise of stock acquisition rights during the first quarter and a further 44,100 shares in November 2021, advancing capital raising. - FY2021AdvancedAnnual report
「During the current consolidated fiscal year, the Company received ¥986.211 million from the issuance of shares.」
Following the public offering and private placement to a third party at the time of listing, 89,400 shares were also issued through the exercise of stock acquisition rights during the current consolidated fiscal year, advancing capital raising for growth investments. - FY2021-Q3AdvancedAnnual report
「In addition, during the cumulative nine-month period of the current consolidated fiscal year, stock acquisition rights were exercised, increasing share capital and capital surplus by ¥7.177 million each.」
Following the public offering and private placement to a third party at the time of listing, additional capital was raised through the exercise of stock acquisition rights. - FY2021-Q2AdvancedAnnual report
「The Company was listed on the Tokyo Stock Exchange Mothers market on 28 October 2020. In connection with the listing, the issue of 350,000 new shares through a public offering, with 27 October 2020 as the payment date, increased share capital and capital surplus by ¥375.130 million each. In addition, payment was received on 30 November 2020 for a private placement to a third party (a private placement associated with the secondary offering through an over-allotment), increasing share capital and capital surplus by ¥108.894 million each.」
Following the public offering at the time of listing, the Company conducted a private placement to a third party on 30 November 2020, advancing capital raising for growth investments. - FY2020First statedAnnual report
「The company was listed on the Tokyo Stock Exchange Mothers market on 28 October 2020.」
The funds raised through the public offering and other means are planned to be invested in and lent to subsidiaries for capital expenditures related to 14 licensed daycare centers scheduled to open in the fiscal year ending July 2021.